Phase II Trial of Thalidomide (Thalidomide Pharmion) in Patients With Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT).
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2009
At a glance
- Drugs Thalidomide (Primary)
- Indications Marginal-zone-B-cell-lymphoma
- Focus Therapeutic Use
- 23 Jun 2009 Actual patient number (8) added as reported by ClinicalTrials.gov.
- 23 Jun 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.